PHARMACOGENOMIC ANALYSIS OF SNPs OF ACE GENE IN STROKE
Abstract
The commonly occurring neurological disorder is stroke disease, which is a third largest killer in the world. Study of genes involved to cause stroke is
one of the way to find drugs for prevention or treatment of stroke. The purpose of the present study is to develop therapeutics by giving individualized
medicine based on significant single-nucleotide polymorphisms (SNPs) involved in the pathogenesis of disease. Genome-wide association approach
scans the entire genome looking through thousands of genetic variants SNPs with an aim to discover novel gene associated with a specific disease.
In the present study, the most intensively investigated candidate gene is angiotensin-I converting enzyme (ACE). The normal and mutated forms of
ACE gene are selected, and the active site of predicted protein structure is identified where the selected ligand binds. The selected ligands of both
existing and modified molecules were docked with predicted protein using AutoDock tool. The docking results were analyzed based on the maximum
number of hydrogen bond interactions. The results predicted that anti-hypertensives, anticoagulants, tissue plasminogen activators (TPAs) have
strong interaction with stroke genes. The docking studies showed that ACE gene strongly interacts with r-TPA and is used for treatment of strokes.
Keywords: Stroke, Single-nucleotide polymorphism, Angiotensin-I converting enzyme, Individualized medicine.
Downloads
References
Bonita R. Epidemiology of stroke. Lancet 1999;339:342-4.
Banerjee TK, Choudhary D, Das A, Sekhar A, Roy D, Sen S. Analysis of hospital-based stroke registry in a neurological centre in Kolkata. J Indian Med Assoc 2005;103(12):665-8.
Padma MV, Kaul S. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide. Neurol India 2007;55(2):141-4.
Munshi A, Kaul S. Stroke genetics - An overview. Neurol India 2010;58(2):181-7.
Kaul S, Munshi A. Genetics of ischemic stroke: Indian perspective. Neurol India 2012;60(5):498-503.
Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987;56:345-8.
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86(4):1343-6.
Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290 (Pt 1):33-40.
Hohenfellner K, Wingen AM, Nauroth O, Wühl E, Mehls O, Schaefer F. Impact of ACE I/D gene polymorphism on congenital renal malformations. Pediatr Nephrol 2001;16(4):356-61.
Das M, Pal S, Ghosh A. Angiotensin converting enzyme gene polymorphism (insertion/deletion) and hypertension in adult Asian Indians: A population-based study from Calcutta, India. Hum Biol 2008;80(3):303-12.
Srivastava K, Srivastava A, Mittal B. Angiotensin-converting enzyme insertion/deletion gene polymorphisms and risk of intracerebral hemorrhage: A meta-analysis of epidemiologic studies. DNA Cell Biol 2008;29:8.
Available from: http://pubchem.ncbi.nlm.nih.gov/search/search.cgi. [Last accessed on 2014 Feb].
Available from: http://www.scripps.edu/mb/olson/doc/autodock. [Last accessed on 2014 May].
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.